Apdime T 500mg/62.5mg Injection
Marketer
Apkavit Lifesciences
Salt Composition
Ceftazidime (500mg) + Tazobactum (62.5mg)
Overview Apdime T 500mg/62.5mg Injection
Combiflox 500mg/62.5mg Injection is a dual-action antibiotic, indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thus limiting infection spread. Administration must be strictly under medical guidance. Consistent adherence to the prescribed dosage schedule is crucial; complete the full course, even with symptom improvement, to prevent treatment failure. Interrupting treatment prematurely may reduce its effectiveness. Commonly reported adverse effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects warrant immediate medical attention. Seek urgent medical assistance for allergic reactions (such as rash, pruritus, edema, or dyspnea). Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't impair driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and ample hydration are recommended for optimal recovery. Your doctor might order blood tests and other diagnostic procedures to monitor the medication's efficacy.
Uses of Apdime T 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Apdime T 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Apdime T 500mg/62.5mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Apdime T 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Apdime T 500mg/62.5mg Injection works:
Apdime T Injection, containing 500mg Ceftazidime and 62.5mg Tazobactum, employs a dual-action approach to combat bacterial infections. Ceftazidime, an antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The beta-lactamase inhibitor, Tazobactum, counteracts bacterial resistance mechanisms, optimizing Ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol co-ingestion with Apdime T 500mg/62.5mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Apdime T (500mg/62.5mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Apdime T 500mg/62.5mg injection poses minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, suggesting no infant harm.
DrivingUNSAFE
Apdime T 500mg/62.5mg Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
For individuals with impaired kidney function, the administration of Apdime T 500mg/62.5mg Injection requires careful monitoring. Dosage modification of Apdime T 500mg/62.5mg Injection might be necessary. A physician's guidance is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Apdime T 500mg/62.5mg Injection with care; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Apdime T 500mg/62.5mg Injection :
Omitting a scheduled Apdime T 500mg/62.5mg Injection requires immediate physician consultation.
Facts to Know About Apdime T 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Category | Agents against infection |
3,018 People bought this recently